GNH USA

Europe — EMA

Mizolen (Mizolastine)

GNH USA supplies Mizolen (Mizolastine), a H1 receptor antagonist for allergic rhinitis, urticaria and other allergic skin conditions.

Mizolastine

Request sourcing

1
Pack/s

What is Mizolastine?

Mizolastine, the active ingredient in Mizolen, is a H1 receptor antagonist presented as an oral tablet for oral use. It is indicated for the relief of symptoms associated with allergic rhinitis, urticaria and other allergic skin conditions in adults, adolescents and children as prescribed under medical supervision.

GNH USA supplies Mizolen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide with a focus on quality assurance and regulatory compliance and timely delivery.

What is Mizolastine used for?

Mizolen (mizolastine) acts on histamine‑mediated pathways to alleviate allergic manifestations.

Allergic rhinitis: reduces nasal congestion, sneezing and itching caused by seasonal or perennial allergens. Urticaria: alleviates wheals and itching in chronic or acute hives. Allergic skin conditions: improves symptoms of eczema and other histamine‑driven dermatoses.

What are the side effects of Mizolastine?

Mizolen may cause adverse reactions, which are classified by frequency and severity.

Common Side Effects: - Drowsiness: mild sedation or sleepiness. - Dry mouth: reduced salivation. - Headache: transient cranial discomfort.

Serious or Rare Side Effects: - Angioedema: swelling of face, lips or throat that may require emergency treatment. - Severe skin rash: including Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Anaphylactic reaction: rapid systemic allergic response that can be life‑threatening.

What precautions apply to Mizolastine?

Before prescribing Mizolen, consider the following safety measures.

Pregnancy: safety not established; use only if benefit outweighs risk. Breastfeeding: caution advised as drug may be excreted in milk. Elderly: increased sensitivity to sedation; monitor for drowsiness. Renal or hepatic impairment: consider dose adjustment and monitor function. Concomitant CNS depressants: may enhance sedative effects; use with caution. Store at room temperature: keep in original packaging, protect from moisture and direct sunlight.

What does Mizolastine interact with?

Mizolen can interact with other medicines; review patient medication lists.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may increase mizolastine plasma levels. - Monoamine oxidase inhibitors: risk of additive antihistaminic effects. - Alcohol: can potentiate sedation.

Moderate Interactions (Monitor Closely): - Other antihistamines: may increase anticholinergic burden. - CNS depressants (benzodiazepines, opioids): monitor for enhanced drowsiness. - Anticholinergic drugs (e.g., diphenhydramine): may increase dry mouth.

Frequently asked questions

What is Mizolen used for?+
Mizolen contains mizolastine, an H1 receptor antagonist that is prescribed to relieve symptoms of allergic rhinitis, urticaria (hives) and other histamine‑driven skin conditions such as eczema. It works by reducing nasal congestion, sneezing, itching and skin wheals associated with these allergic disorders.
How does mizolastine work?+
Mizolastine selectively blocks peripheral H1 histamine receptors, preventing histamine from triggering the cascade that causes vasodilation, increased vascular permeability, and nerve irritation. By inhibiting this pathway, the drug diminishes both early and late phase allergic responses, leading to reduced itching, swelling and other allergy symptoms.
What is the usual dose of Mizolen?+
The appropriate dose of Mizolen is determined by the prescribing healthcare professional based on the patient’s age, weight, severity of symptoms and any co‑existing medical conditions. Dosage recommendations are individualized, and patients should follow the prescriber’s instructions without altering the regimen.
Is Mizolen safe during pregnancy or breastfeeding?+
Safety data for mizolastine in pregnancy and lactation are limited, and the product is classified as having an unknown pregnancy category. It should only be used if the potential benefit justifies any possible risk to the fetus, and breastfeeding mothers should consult their physician before use.
How do I order Mizolen from GNH USA?+
To request Mizolen, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.
How does Mizolen compare with other antihistamines?+
Mizolastine is a second‑generation H1 antagonist that offers effective allergy relief with a lower propensity for central nervous system effects compared with many first‑generation antihistamines. Its selectivity for peripheral H1 receptors often results in reduced drowsiness, though individual responses may vary.
How should Mizolen be stored and handled?+
Mizolen tablets should be stored at room temperature, below 25 °C, in the original blister pack or container. Protect the product from moisture, direct sunlight and excessive heat to maintain potency throughout its shelf life.
How is Mizolen administered?+
Mizolen is taken orally, usually with a glass of water. The tablet should be swallowed whole and not chewed or crushed unless specifically instructed by a healthcare professional. Administration timing (e.g., with or without food) follows the prescriber’s guidance.
What are the most serious risks to watch for while taking Mizolen?+
Although uncommon, serious adverse reactions can include angioedema (swelling of the face, lips or throat), severe skin rashes such as Stevens‑Johnson syndrome, and anaphylactic reactions. Patients experiencing any of these symptoms should seek immediate medical attention.
Who should not use Mizolen?+
Mizolen is contraindicated in individuals with known hypersensitivity to mizolastine or any of the tablet’s excipients. Caution is also advised for patients with severe hepatic or renal impairment, and it should be avoided in those taking medications that have a major interaction risk unless closely monitored.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Mizolastine
Route
Oral Use
Manufacturer
Opella Healthcare Spain, S.L
Origin
EU

Related products

Mizocler

Mizocler

Mizolastine

Desma Pharma
EU
Mizollen

Mizollen

Mizolastine

Desma Pharma
EU
Mizollen

Mizollen

Mizolastine

A. Nattermann & Cie. Gmbh
EU
Mizollen

Mizollen

Mizolastine

Opella Healthcare Italy S.R.L.
EU